McMillan Office’s Humana HUM Stock Holding History

McMillan Office’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Hold	4,816	–	–	0.22%	57
2026 Q1	$835K	Hold	4,816	–	–	0.11%	89
2025 Q4	$1.23M	Buy	+4,816	New	+$1.26M	0.15%	72

Other funds holding HUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

McMillan Office's HUM Position: Q2 2026 in Review

McMillan Office held its Humana (HUM) position steady in Q2 2026 at 4,816 shares worth $1.91M. The position accounts for 0.22% of the portfolio, ranked #57.

McMillan Office first reported a position in HUM in Q4 2025 and has held it in 3 quarters since. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

McMillan Office held 4,816 shares of Humana worth $1.91M as of Q2 2026.
McMillan Office left its Humana share count unchanged in Q2 2026.
Humana made up 0.22% of McMillan Office's portfolio in Q2 2026, its #57 holding.
McMillan Office first reported a position in Humana in Q4 2025 and has held it in 3 quarters since.
924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.